Producing with Certainty and Agility
Smart systems that enable repeatable, compliant, and efficient biomanufacturing
Batch processes have become increasingly complex for life science companies, particularly on the pharmaceutical production side where proper data measurement and analysis is essential to profitability. Emerson offers intelligent automated batch solutions that not only can provide accurate data measurement, but also reduce variability, enhance product utilization, and maximize yield for more effective batch processes.
Simplify and Optimize Batch Processes
Whether producing monoclonal antibodies or vaccines, batch processes demand repeatable performance and real-time insight. Modern platforms integrate scheduling, automation, and data management into a unified environment that supports electronic batch records, analytics, and ongoing improvements. By reducing manual interventions and centralizing operations, teams can improve throughput while maintaining strict adherence to GMP standards.
Technologies That Power End-to-End Batch Control
Enable continuous manufacturing with automation.
DeltaV™ Batch Executive
Centralized recipe management and execution platform for full batch process control enables repeatability, auditability, and scalability across operations.
DeltaV™ Manufacturing Execution System
Digitally manages electronic batch records, materials, and equipment tracking, and improves visibility and reduces documentation effort.
AMS for Reliability
Predictive maintenance platform that integrates with batch operations to minimize downtime and preserve product quality.
Solution-Related Documents for Batch
Access a curated library of technical documents, case studies, and solution overviews designed to support batch process optimization. These resources demonstrate how Emerson’s technologies help enhance repeatability, streamline regulatory compliance, and drive greater efficiency across every stage of batch production.
Business Groups in Batch
Successful batch manufacturing requires more than a single system—it needs synchronized technologies that span control, measurement, and asset reliability. Business groups across the portfolio offer specialized tools that enable consistent batch outcomes, reduce variability, and improve compliance. Together they create an environment where data, processes, and people are connected for long-term Operational Excellence.
Automation Systems
Frequently Asked Questions (FAQs)
Explore answers to frequently asked questions about batch processing in biotechnology manufacturing. Learn how automation, recipe management, and digital batch records support consistent quality, regulatory compliance, and efficient scale-up from clinical to commercial production.
Batch processing is a production method where a specific quantity of a drug product is produced in a single, defined run. It is commonly used in biotechnology to ensure consistency, traceability, and regulatory compliance across multiple stages of drug development and manufacturing.
Batch automation streamlines execution by minimizing manual interventions, ensuring recipe adherence, and providing real-time monitoring and control. This leads to faster production cycles, reduced errors, and enhanced product quality.
Core components include a batch execution engine, recipe management, operator interface, real-time data capture, electronic records, and integration with MES and automation systems.
ISA-88 is a widely adopted standard for batch process control. It provides a framework for defining recipes, equipment modules, and control strategies, supporting scalable and flexible batch operations in biotechnology manufacturing.
Batch processing is discrete and time-bound, which is ideal for high-mix, low-volume production. Continuous processing runs non-stop and is used for high-volume, consistent product manufacturing. Batch remains more common in biologics due to complexity and regulatory factors.
Effective recipe management ensures precise ingredient quantities, consistent processing steps, and repeatable results, which are critical in the production of biologics and other high-value therapeutics.